ACTRN12621000560897已完成1 期
Safety and tolerability of psilocybin-assisted physiotherapy in healthy volunteers
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 13
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 65 Years（—）
- 性别
- All
入选标准
- •Adults aged 18 to 65 years, without a history of Functional Neurological Disorder (FND), who have volunteered for the study.
- •Capacity to provide informed consent
排除标准
- •--- Medical exclusion criteria ---
- •Cardiovascular conditions: poorly-controlled hypertension, angina, ischemic heart disease, a clinically significant ECG abnormality (e.g. atrial fibrillation), transient ischemic attack (TIA), stroke, peripheral or pulmonary vascular disease (no active claudication).
- •A diagnosis of epilepsy or previous epileptic seizures.
- •Diagnosis of dementia
- •A history of Chronic Kidney Disease or Chronic Liver Disease
- •Known conditions putting the participant at risk for hypercalcaemia, Cushing's syndrome, hypoglycaemia, syndrome of inappropriate antidiuretic hormone secretion, or carcinoid syndrome.
- •Insulin-dependent diabetes; if taking oral hypoglycaemic agents, the participant is only excluded if they also have a history of hypoglycaemia.
- •Females who are pregnant, nursing or trying to conceive.
- •Use of medications contraindicated with psilocybin, that are inappropriate to cease for the necessary time period before/after the dosing session.
- •Patients enrolled in another clinical trial involving an investigational product.
- •--- Psychological exclusion criteria ---
- •Current or previous diagnosis of any psychotic disorder, including Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder, Brief Psychotic Disorder, Delusional Disorder, Schizotypal Personality Disorder, Substance/Medication-Induced Psychotic Disorder or Psychotic Disorder due to another medical condition.
- •Current or previous diagnosis of Bipolar disorder.
- •First degree relative with diagnosed Schizophrenia, Psychotic Disorder, or Bipolar Disorder.
- •A history of attempted suicide or mania.
- •Current or previous diagnosis of substance use disorder (excluding caffeine and nicotine).
- •Previous regular use, or current use of psychedelic agents.
- •Current diagnosis of other psychiatric conditions judged to be incompatible with safe exposure to psilocybin
研究者
相似试验
招募中
1 期
Psilocybin-assisted physiotherapy for refractory Functional Neurological DisorderFunctional neurological disorderMental Health - Other mental health disordersNeurological - Other neurological disordersACTRN12621000578808Austin Health24
招募中
Unknown
Psilocybin administration for treatment-resistant depressiodepressionD061218Treatment-resistant depressionJPRN-jRCTs031230351chida Hiroyuki12
已完成
2 期
Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression (EPIsoDE)F32.1F32.2F33.1F33.2Moderate depressive episodeSevere depressive episode without psychotic symptomsRecurrent depressive disorder, current episode moderateRecurrent depressive disorder, current episode severe without psychotic symptomsDRKS00024484Zentralinstitut für Seelische Gesundheit144
进行中（未招募）
1 期
The safety and efficacy of psilocybin as an adjunctive therapy in participants with treatment-resistant depressiotreatment resistant depressionMedDRA version: 21.1Level: LLTClassification code 10025454Term: Major depressive disorder, recurrent episodeSystem Organ Class: 100000004873MedDRA version: 21.1Level: LLTClassification code 10025463Term: Major depressive disorder, single episodeSystem Organ Class: 100000004873EUCTR2018-002577-22-IECOMPASS Pathfinder, Limited20
进行中（未招募）
1 期
The Safety and Efficacy of Psilocybin in Participants with Treatment Resistant DepressioTreatment-Resistant Depression (P-TRD)MedDRA version: 21.1Level: LLTClassification code 10025454Term: Major depressive disorder, recurrent episodeSystem Organ Class: 100000004873MedDRA version: 21.1Level: LLTClassification code 10025463Term: Major depressive disorder, single episodeSystem Organ Class: 100000004873EUCTR2017-003288-36-CZCOMPASS Pathfinder, Limited216